275 related articles for article (PubMed ID: 29168213)
1. Economic assessment of actual prescription of drugs for treatment of atopic dermatitis: Differences between dermatology and pediatrics in large-scale receipt data.
Komura Y; Kogure T; Kawahara K; Yokozeki H
J Dermatol; 2018 Feb; 45(2):165-174. PubMed ID: 29168213
[TBL] [Abstract][Full Text] [Related]
2. An over-the-counter moisturizer is as clinically effective as, and more cost-effective than, prescription barrier creams in the treatment of children with mild-to-moderate atopic dermatitis: a randomized, controlled trial.
Miller DW; Koch SB; Yentzer BA; Clark AR; O'Neill JR; Fountain J; Weber TM; Fleischer AB
J Drugs Dermatol; 2011 May; 10(5):531-7. PubMed ID: 21533301
[TBL] [Abstract][Full Text] [Related]
3. Comparative effectiveness of topical calcineurin inhibitors in adult patients with atopic dermatitis.
Frankel HC; Qureshi AA
Am J Clin Dermatol; 2012 Apr; 13(2):113-23. PubMed ID: 22263704
[TBL] [Abstract][Full Text] [Related]
4. The cost of atopic dermatitis in the Netherlands: an international comparison.
Verboom P; Hakkaart-Van L; Sturkenboom M; De Zeeuw R; Menke H; Rutten F
Br J Dermatol; 2002 Oct; 147(4):716-24. PubMed ID: 12366418
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness analysis of tacrolimus ointment versus high-potency topical corticosteroids in adults with moderate to severe atopic dermatitis.
Ellis CN; Drake LA; Prendergast MM; Abramovits W; Boguniewicz M; Daniel CR; Lebwohl M; Paller AS; Stevens SR; Whitaker-Worth DL; Tong KB
J Am Acad Dermatol; 2003 Apr; 48(4):553-63. PubMed ID: 12664019
[TBL] [Abstract][Full Text] [Related]
6. Prescriptions for atopic dermatitis: oral corticosteroids remain commonplace.
Alexander T; Maxim E; Cardwell LA; Chawla A; Feldman SR
J Dermatolog Treat; 2018 May; 29(3):238-240. PubMed ID: 28789575
[TBL] [Abstract][Full Text] [Related]
7. [Diagnostic, prophylactic and therapeutic guidelines in patients with atopic dermatitis. Position paper by the task force of the National Specialists on Dermatology, Venereology and Allergology].
Gliński W; Kruszewski J; Silny W; Kurzawa R; Czarnecka-Operacz M; Baran E; Szepietowski J;
Pol Merkur Lekarski; 2004; 17 Suppl 3():3-15. PubMed ID: 15688665
[TBL] [Abstract][Full Text] [Related]
8. Spotlight on topical pimecrolimus in pediatric atopic dermatitis.
Yang LP; Curran MP
Am J Clin Dermatol; 2010; 11(4):295-8. PubMed ID: 20509720
[TBL] [Abstract][Full Text] [Related]
9. Potential barriers to adherence in pediatric dermatology.
Ellis RM; Koch LH; McGuire E; Williams JV
Pediatr Dermatol; 2011; 28(3):242-4. PubMed ID: 21615470
[TBL] [Abstract][Full Text] [Related]
10. Burden of Atopic dermatitis in Canada.
Barbeau M; Bpharm HL
Int J Dermatol; 2006 Jan; 45(1):31-6. PubMed ID: 16426372
[TBL] [Abstract][Full Text] [Related]
11. Generic drugs in dermatology: part II.
Payette M; Grant-Kels JM
J Am Acad Dermatol; 2012 Mar; 66(3):353.e1-15; quiz 367-8. PubMed ID: 22342022
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of tacrolimus ointment vs. standard treatment in patients with moderate and severe atopic dermatitis: a health-economic model simulation based on a patient survey and clinical trial data.
Hjelmgren J; Svensson A; Jörgensen ET; Lindemalm-Lundstam B; Ragnarson Tennvall G
Br J Dermatol; 2007 May; 156(5):913-21. PubMed ID: 17263826
[TBL] [Abstract][Full Text] [Related]
13. The Usage of Hypoallergenic Cosmetics in Patients with Atopic Dermatitis.
Zeljko Penavić J; Šimić D; Petrušić I; Kraljević M; Sulić AM
Acta Dermatovenerol Croat; 2018 Jun; 26(2):105-108. PubMed ID: 29989865
[TBL] [Abstract][Full Text] [Related]
14. A cost-utility analysis of pimecrolimus vs. topical corticosteroids and emollients for the treatment of mild and moderate atopic eczema.
Pitt M; Garside R; Stein K
Br J Dermatol; 2006 Jun; 154(6):1137-46. PubMed ID: 16704646
[TBL] [Abstract][Full Text] [Related]
15. Calcineurin inhibitors in pediatric atopic dermatitis: a review of current evidence.
Kalavala M; Dohil MA
Am J Clin Dermatol; 2011 Feb; 12(1):15-24. PubMed ID: 21067248
[TBL] [Abstract][Full Text] [Related]
16. Generic drugs in dermatology: part I.
Payette M; Grant-Kels JM
J Am Acad Dermatol; 2012 Mar; 66(3):343.e1-8; quiz 351-2. PubMed ID: 22342021
[TBL] [Abstract][Full Text] [Related]
17. Executive summary: American Academy of Dermatology guidelines of care for the management of atopic dermatitis in adults with topical therapies.
Sidbury R; Alikhan A; Bercovitch L; Cohen DE; Darr JM; Drucker AM; Eichenfield LF; Frazer-Green L; Paller AS; Schwarzenberger K; Silverberg JI; Singh AM; Wu PA; Davis DMR
J Am Acad Dermatol; 2023 Jul; 89(1):128-129. PubMed ID: 36623556
[TBL] [Abstract][Full Text] [Related]
18. Effect of sequential applications of topical tacrolimus and topical corticosteroids in the treatment of pediatric atopic dermatitis: an open-label pilot study.
Kubota Y; Yoneda K; Nakai K; Katsuura J; Moriue T; Matsuoka Y; Miyamoto I; Ohya Y
J Am Acad Dermatol; 2009 Feb; 60(2):212-7. PubMed ID: 19027990
[TBL] [Abstract][Full Text] [Related]
19. Dermatologists and allergists have far more experience and use more complex treatment regimens in the treatment of atopic dermatitis than other physicians.
Henderson RL; Fleischer AB; Feldman SR
J Cutan Med Surg; 2001; 5(3):211-6. PubMed ID: 11685667
[TBL] [Abstract][Full Text] [Related]
20. Clinical and cytological effects of pimecrolimus cream 1% after resolution of active atopic dermatitis lesions by topical corticosteroids: a randomized controlled trial.
Bangert C; Strober BE; Cork M; Ortonne JP; Luger T; Bieber T; Ferguson A; Ecker RC; Kopp T; Weise-Riccardi S; Guettner A; Stingl G
Dermatology; 2011 Feb; 222(1):36-48. PubMed ID: 21150167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
